Industrial Goods » Precision Products | Uniroyal Global Engineered Products Inc.

Uniroyal Global Engineered Products Inc. | Income Statement

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
26.80
98,323.20
99,762.00
100,377.30
98,138.10
99,560.70
Cost of Goods Sold (COGS) incl. D&A
11.30
79,004.20
77,813.40
77,515.30
79,726.40
82,623
Gross Income
15.50
19,319.00
21,948.60
22,862.00
18,411.70
16,937.80
SG&A Expense
307.30
13,750.90
14,709.10
14,815.30
13,866.80
13,389.60
EBIT
291.80
5,568.10
7,239.50
-
4,544.80
3,548.20
Unusual Expense
45.00
906.00
-
-
-
510.20
Non Operating Income/Expense
-
232.70
65.40
249.60
81.20
96.70
Interest Expense
111.10
1,595.00
1,613.40
1,616.10
1,654.70
1,886.90
Pretax Income
357.90
3,299.80
5,560.80
6,180.90
2,808.90
1,054.40
Income Tax
-
1,340.70
2,193.10
1,198.60
2,916.10
192.40
Consolidated Net Income
357.90
4,640.50
7,753.80
7,379.50
107.20
1,246.80
Net Income
357.90
4,640.50
7,753.80
7,379.50
107.20
1,246.80
Net Income After Extraordinaries
357.90
4,640.50
7,753.80
7,379.50
107.20
1,246.80
Net Income Available to Common
357.90
4,236.90
4,952.20
4,499.70
3,102.10
1,859.20
EPS (Basic)
0.03
0.22
0.26
0.24
0.17
0.10
Basic Shares Outstanding
14,214.40
14,181.00
14,334.50
18,828.40
18,704.80
18,690
EPS (Diluted)
0.03
0.22
0.26
0.24
0.17
0.10
Diluted Shares Outstanding
14,214.40
18,937.80
19,040.00
18,869.70
18,704.80
18,690
EBITDA
291.80
7,004.10
8,810.80
9,773.70
6,431.20
5,743.80
Preferred Dividends
-
403.60
2,801.70
2,879.80
2,994.90
3,106

About Uniroyal Global Engineered Products

View Profile
Address
1800 2nd Street
Sarasota Florida 34236
United States
Employees -
Website http://www.uniroyalglobal.com
Updated 07/08/2019
Uniroyal Global Engineered Products, Inc. engages in the manufacture and sale of vinyl coated fabrics. It specializes in branded coated fabrics, automotive and transportation interior as well as calendered sheeting. It operates through the following brands: Naugahyde, BeautyGard, Flameblocker, Spirit Millennium, Ambla, Amblon, Velbex, Cirroflex, Plastolene, and Vynide.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.